Health
Inhaled steroid ciclesonide suppresses SARS-CoV-2 replication in vitro – News-Medical.Net
A new paper by researchers at Japan’s National Institute of Infectious Diseases and published on the preprint server bioRxiv in August 2020 reports the in vitro suppression of coronavirus (CoV) replication by an inhaled corticosteroid (ICS) ciclesonide.
With the COVID-19 pandemic, the world has suffered hundreds of thousands of deaths and tens of millions of cases. In order to contain this outbreak, new and already approved drugs are being tested. A new paper by researchers at Japan’s National Institute of Infectious Diseases and published on the preprint server bioRxiv* in August 2020 reports the in vitro suppression of coronavirus (CoV) replication by an inhaled corticosteroid (ICS) ciclesonide.
Steroids have been repurposed for the treatmen…
-
Noosa News16 hours agoTeenage boy crashes into Ipswich home, left fighting for life in hospital
-
General19 hours agoNZ PM wants united trade bloc-EU response to tariffs
-
General21 hours agoShored against our ruins
-
Noosa News24 hours agoCity of Moreton Bay throws homeless people’s tents into garbage trucks